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he nematode worm, C. elegans, 
sheds its exoskeleton at particular 
life stages, and Alison Frand be-
lieves that understanding this molting 
process might provide new insights into 
diseases affecting humans. Some of the 
potential medical benefi  ts lie in the simi-
larities between the worms’ exoskeleton 




might lie in the 
unique aspects of 
worm molting.
Frand loves 
worms. But this 
love affair didn’t 
start until her 
postdoc years in Gary Ruvkun’s lab. Before 
that, as a Ph.D. student at MIT, she was 
happily married to protein disulfi  de bond 
formation in yeast (1–3). Then, in Ruvkun’s 
lab at Harvard, she worked on a landmark 
study using a reverse genetic screen to 
identify and characterize the genes in-
volved in worm molting (4). And there 
was no looking back.
Now, armed with the results of that 
screen, Frand is continuing her work on 
molting at UCLA (5), where she heads 
her own lab. We pinned her down to ask 
about how she, as a young scientist, shed 
her protein biologist skin and became 
interested in molting.
BIOLOGY ALL THE WAY
What ﬁ  rst got you interested in science?
I fi  rst got interested in science in middle 
school. I had a teacher named Sharon 
Sicher, who mentored a whole group of 
students in an after-school science pro-
gram.
Then, in high school, I had another 
mentor, Dr. William Ritter. The dedica-
tion of these teachers really nurtured my 
interest in science and my sense that it 
was a rewarding endeavor and something 
I wanted to keep doing.
Were you always interested in a career 
in biology?
Always biology. And I think my experi-
ences have really built on each other. First, 
I was interested in marine invertebrate 
zoology—in high school, I thought I 
wanted to study water bugs. Then, as a 
biology major at Cornell, I did an under-
graduate project on translation in mito-
chondria with Tom Fox. Working in Tom’s 
lab prepared me to work on protein fold-
ing at MIT, and I think the work at MIT 
prepared me to develop an independent 
project on the molting cycle in my post-
doc. All along, I was fortunate in fi  nding 
really great training environments and 
really outstanding mentors.
What draws you to doing research?
I have such a sense of joy at my bench. I like 
to form hypotheses and test them. I like to 
see the data, to know whether or not the 
way I’m thinking about something is 
right. It’s a very gratifying experience. 
And if the data tell you something is 
working in a different way than you imag-
ined, in that case there’s more to learn. I 
love the process of always asking the next 
question, continuing to go deeper and 
continuing to see how much of a problem 
we can understand. Being at the bench 
is my path to that experience.
A NATURAL EVOLUTION
How did you arrive at studying 
protein disulﬁ  de bond formation 
as a graduate student?
When I chose a graduate lab, I was look-
ing for the right mentor. I had taken a 
graduate biology course with Chris Kaiser 
called Methods and Logic, and I saw him 
as someone with a tremendous set of 
scientifi   c skills. He was still relatively 
new at the time, and I specifi  cally wanted 
to work for a younger PI who was active 
in the lab. I also wanted to work in a sys-
tem where I thought that I could learn a 
whole lot of techniques. Yeast was a great 
training ground—I learned genetics, cell 
biology, and biochemistry. I thought that 
if I had a broad set of skills, I would be in 
a good position to tackle whatever scien-
tifi  c questions came later.
When I joined Chris’s lab, the focus was 
the study of the secretory pathway. The lab 
was doing screens to fi  nd new secretory 
mutants, and I started out identifying the 
genes that were defective. One of the 
genes that I cloned turned out to encode 
an enzyme that catalyzes the formation of 
disulfi  de bonds. Without it, some proteins 
don’t fold properly and get held back in the 
endoplasmic reticulum. This discovery was 
exciting because at the time there was a 
beautiful body of work studying disulfi  de 
bond formation in vitro, but not as much 
was known about how disulfi  de  bonds 
formed in the eukaryotic cell.
In your postdoctoral work, you moved to 
a very different ﬁ  eld—what motivated 
the switch?
When I started looking for postdocs, I 
really wanted to ask questions about bi-
ology at the level of the organism. I 
found the molting cycle of nematodes 
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fascinating. C. elegans has an external 
skeleton made of collagen. It’s similar 
to human skin and connective tissue, 
and it serves many of the same functions 
as our skeleton. As worms develop, once 
every eight hours they take apart this 
elaborate skeleton and make a new one. 
That process of renewing the skeleton 
has to be coordinated in epidermal cells 
all over the body. The animal also has to 
integrate sensory and physiological cues 
to know when to execute the renewal. 
It’s really very exciting.
The reverse genetic screen we did in 
Ruvkun’s lab identifi   ed many of the 
genes required for the worm to shed the 
skeleton. Some of the genes were found 
only in nematodes, and so they may rep-
resent new drug targets for diseases 
caused by parasitic nematodes. Such 
diseases currently affect 140 million 
people in tropical regions.
We also found genes that encode en-
zymes and matrix proteins homologous 
to vertebrate proteins. For example, one 
of the genes encodes the orthologue of 
human fi  brillin, a component of extra-
cellular matrix fi  bers that’s defective in 
Marfan’s syndrome.
LOOKING TO THE NEXT STAGE
Your screen for molting genes involved 
introducing RNAi to the worms by 
feeding them modiﬁ  ed bacteria?
Yes. We feed the worms bacteria that 
make double-stranded RNA matched to 
a particular worm gene. The worms eat 
the bacteria, the RNA gets in their gut, 
and then it spreads throughout the body, 
silencing the gene. The bacterial library 
was made by Julie Ahringer’s laboratory, 
and the Ruvkun lab was very fortunate 
to receive the library relatively early. 
Genome-wide screens were a new approach. 
As a graduate student, I had worked on 
one gene. So it was a real shift in think-
ing, coming to a place where you could 
look at the whole genome. And then you 
have to go on to ask what you can do 
with the genomic information once you 
have it.
How did you know when you were 
ready to move on to the next step in 
your career?
As a postdoc, I got to focus on a new 
scientifi  c question.  When PloS Biology 
published my paper, I felt that I had 
made progress on that problem.  That’s 
when I felt I was ready to start my own 
lab. I don’t know if anyone ever feels 
totally prepared to become the head of a 
lab, but I’ll do the best I can.
What problems are you focusing on 
now in your own lab?
There are two major questions that we’re 
studying. We want to understand how neuro-
endocrine circuits regulate the molting cycle 
as a model for the hormonal control of 
development. So, we want to understand 
how physiologic signals 
trigger or repress remod-
eling of the skeleton, and 
how the worm’s behav-
ior is coordinated with 
the molt. Our other ma-
jor focus is to understand 
the molecular mecha-
nisms for remodeling 
the skeleton. Ideally, 
we’d like to know what every membrane 
protein and every matrix protein uncovered 
in our screen has to do when it’s time to 
make a new skeleton, and how the proteins 
work together to accomplish that task.
I am so excited to be here at UCLA, 
starting a lab and watching it grow. You get 
to a point where you have so many ideas 
that it’s not possible for you to research 
them on your own, and you need a group of 
people working together to explore and 
expand those ideas and take the work in new 
directions. I hope that my interactions with 
graduate students honor the commitment of 
my mentors. If I could be as good a mentor 
as the ones I’ve had, that would feel like a 
signifi  cant contribution. 
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A GFP reporter shows expression of the mlt-11 gene during molting.